Sai Life Sciences Intrinsic Value
Sai Life Sciences intrinsic value. Sai Life Sciences (SAILIFE) median intrinsic value is ₹2365.71 from 9 valuation models (range ₹537–₹3577), vs current price ₹1788.40 — +32.3% upside (Trading Below Calculated Value), margin of safety 24.4%. For current market price and key ratios, visit Sai Life Sciences share price screener.
SAILIFE Valuation Methods Summary — DCF, Graham Number & P/E
Sai Life Sciences intrinsic value across 9 models vs current price ₹1788.40 — upside/downside and value range per method. Browse SAILIFE financial statements for revenue, profit, balance sheet and cash flow data.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹536.52 | ₹429.22 - ₹643.82 | -70.0% | EPS: ₹18.52, Sector P/E: 22x |
| Book Value Method | asset | ₹2365.71 | ₹2129.14 - ₹2602.28 | +32.3% | Book Value/Share: ₹1182.86, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹2525.71 | ₹2273.14 - ₹2778.28 | +41.2% | Revenue/Share: ₹1262.86, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹3576.80 | ₹3219.12 - ₹3934.48 | +100.0% | EBITDA: ₹760.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹3292.34 | ₹2633.87 - ₹3950.81 | +84.1% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹536.52 | ₹482.87 - ₹590.17 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹536.52 | ₹482.87 - ₹590.17 | -70.0% | Revenue Growth: 6.0%, Adj P/E: 15.5x |
| ROE Based Valuation | profitability | ₹2613.33 | ₹2352.00 - ₹2874.66 | +46.1% | ROE: 15.8%, P/E Multiple: 14x |
| Graham Defensive Method | conservative | ₹702.07 | ₹631.86 - ₹772.28 | -60.7% | EPS: ₹18.52, BVPS: ₹1182.86 |
SAILIFE Intrinsic Value vs Market Price — All Valuation Models
Sai Life Sciences fair value range ₹537–₹3577 vs current market price ₹1788.40 across 9 valuation models. Analyse Sai Life Sciences ownership pattern to track promoter, FII and institutional holdings.
SAILIFE Intrinsic Value Analysis — Undervalued or Overvalued?
Sai Life Sciences median intrinsic value ₹2365.71, current price ₹1788.40 — Trading Below Calculated Value by 32.3%, margin of safety 24.4%.
What is the intrinsic value of SAILIFE?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Sai Life Sciences (SAILIFE) is ₹2365.71 (median value). With the current market price of ₹1788.40, this represents a +32.3% variance from our estimated fair value.
The valuation range spans from ₹536.52 to ₹3576.80, indicating ₹536.52 - ₹3576.80.
Is SAILIFE undervalued or overvalued?
Based on our multi-method analysis, Sai Life Sciences (SAILIFE) appears to be trading below calculated value by approximately 32.3%.
SAILIFE Financial Health — Key Ratios vs Industry Benchmarks
Sai Life Sciences financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Return on Equity | 15.8% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 28.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.73x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
SAILIFE Cash Flow Quality — Operating & Free Cash Flow
Sai Life Sciences operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹509 Cr | ₹312 Cr | Positive Free Cash Flow | 8/10 |
| March 2025 | ₹314 Cr | ₹46 Cr | Positive Free Cash Flow | 7/10 |
| March 2024 | ₹263 Cr | ₹168 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹219 Cr | ₹170 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹105 Cr | ₹54 Cr | Positive Free Cash Flow | 8/10 |